Innovotech Inc. (TSXV:IOT)

Market Cap	13.52M +230.9%
Revenue (ttm)	4.46M +199.1%
Net Income	383.41K
EPS	0.01
Shares Out	52.00M
PE Ratio	37.19
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,727
Average Volume	21,371
Open	0.2400
Previous Close	n/a
Day's Range	0.2400 - 0.2600
52-Week Range	0.1000 - 0.3400
Beta	0.99
RSI	51.16
Earnings Date	Apr 24, 2026

About Innovotech

Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assay lids; and order biofilm assays. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; an...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Craig Milne
• Employees: 16
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: IOT